Bjorn Knollmann
-
January 14, 2016
Knollmann to direct new arrhythmia research center
Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART). -
January 14, 2016
New method aids heart disease studies, drug discovery efforts
A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells. -
May 12, 2014
Normalizing calcium flux to treat atrial fibrillation
A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation. -
July 26, 2013
Reducing fatal rhythms after heart attack
Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks. -
November 16, 2012
Green tea for failing hearts?
The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure.